Universidad Nacional de Colombia. Sede Bogotá. Facultad de Ciencias. Departamento de Farmacia. Ciudad Universitaria, Carrera 30 45-03, Edificio 450, Bogotá postal code 111321, Colombia.
Universidad Nacional de Colombia. Sede Bogotá. Facultad de Ciencias. Departamento de Farmacia. Ciudad Universitaria, Carrera 30 45-03, Edificio 450, Bogotá postal code 111321, Colombia.
Int J Pharm. 2022 Feb 25;614:121440. doi: 10.1016/j.ijpharm.2021.121440. Epub 2022 Jan 5.
Nanoprecipitation is a practical method to prepare carriers at the nanometric scale, which attracts attention in pharmaceutics because of its low cost, easy setup, the versatility of the starting materials, possibility to obtain different kinds of carriers, and minimal environmental impact. Since 1986, this technique has been extensively employed in research; therefore, this paper focuses on state of art regarding inventions wherein it is employed. To this end, 133 nanoprecipitation-based patent families are identified in the PatSnap® platform, which allows identifying general trends. Afterwards, a sample of 40 patent families reported as granted (21 families) or patent applications (19 families) during the last decade are studied in depth to establish the research tendencies. Undoubtedly, Chinese universities are positioned as leaders in this field, and cancer treatments are the more claimed use followed far behind for developments targeting neurodegenerative and diabetes diseases. New proposals on targeted and stimuli response particles are also claimed, and development of polymers, prodrugs, and improvements to the technique such as the flash-nanoprecipitation, use of microfluidics, or design of green process are relevant. Interestingly, nanoprecipitation-related patent families have significantly increased during the last decade, being the 71% of the total, which makes alluring the perspectives about its industrial harnessing.
纳米沉淀法是一种制备纳米级载体的实用方法,由于其成本低、易于设置、起始材料的多功能性、能够获得不同类型的载体以及对环境的影响最小,因此在药剂学中引起了关注。自 1986 年以来,这项技术已在研究中得到广泛应用;因此,本文重点介绍了该技术的发明现状。为此,在 PatSnap®平台上确定了 133 个基于纳米沉淀的专利家族,从而可以识别出总体趋势。此后,对过去十年中获得授权的 40 个专利家族(21 个家族)或专利申请(19 个家族)进行了深入研究,以确定研究趋势。毫无疑问,中国的大学在该领域处于领先地位,癌症治疗是申请最多的用途,其次是针对神经退行性疾病和糖尿病的开发。还提出了针对靶向和刺激响应颗粒的新建议,聚合物、前药的开发以及对技术的改进(如闪式纳米沉淀、微流控的使用或绿色工艺的设计)也很重要。有趣的是,与纳米沉淀相关的专利家族在过去十年中显著增加,占总数的 71%,这使得人们对其工业利用的前景充满了吸引力。